Ticker
FATECompany Name
FATE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -118.64M | -109.91% | $ 107.95M |
3/31/2025 | $ -125.17M | -109.19% | $ 114.63M |
12/31/2024 | $ -123.6M | -119.18% | $ 103.71M |
9/30/2024 | $ -132.53M | -48.89% | $ 271.07M |
6/30/2024 | $ -141.45M | -37.19% | $ 380.35M |
3/31/2024 | $ -139.78M | -31.49% | $ 443.94M |
12/31/2023 | $ -138.42M | -20.07% | $ 689.7M |
9/30/2023 | $ -183.66M | -79.94% | $ 229.74M |
6/30/2023 | $ -208.55M | -59.94% | $ 347.93M |
3/31/2023 | $ -241.15M | -38.78% | $ 621.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Market Cap
(=) FCF Yield
FCF Yield for FATE THERAPEUTICS INC is calculated as follows: FCF [ $ -49.35M ] / Market Cap [ $ 4.36B ]
(=) FCF Yield [ -1.13% ]
Minimum
Dec 31, 2024
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.26% |
std | 11.36% |